Xilio Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $24.1M | $60.9M | $44.7M |
| FY2024 | $53.5M | $71.1M | $55.3M |
| FY2025 | $119.4M | $154.7M | $137.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $24.1M | $60.9M | $44.7M |
| FY2024 | $53.5M | $71.1M | $55.3M |
| FY2025 | $119.4M | $154.7M | $137.5M |